Navigating Through Mechanistic Features and Treatment Strategies During PCI for Stent Failure

  • Views:

    Views Icon 100
  • Likes:

    Heart Icon 0


Stent failure remains a significant challenge in the treatment of CAD, and a recurring burden within the complex PCI setting. This webinar aims to best illustrate how understanding of the mechanisms that trigger the onset of ISR is key in determining treatment strategies and how – through algorithms and case-based tips and tricks – to maximise outcomes with diagnostic and treatment technologies.

Performed By:

Peter O’Kane

Peter O’Kane

This webinar is supported by:

Key Learning Objectives

  • Recognise the interacting factors that can lead to stent failure
  • Understand how effectively physiological assessment can guide PCI for angiographic restenosis
  • Demonstrate how routine use of using intra-coronary imaging can identify the aetiology of stent failure
  • Through case-based examples show how specific devices for lesion preparation can be efficiently targeted toward the mechanism of restenosis to optimise PCI for long term durability

Target Audience

  • Interventional Cardiologists
  • Interventional Fellows
  • Registrars with an interest in interventional cardiology

Faculty Biographies

Peter O’Kane

Peter O’Kane

Dr Peter O’Kane was appointed as a consultant interventional cardiologist at Royal Bournemouth Hospital in July 2007 and has performed more than 7000 PCI cases. He has extensive experience with coronary physiology and intra-coronary imaging to guide intervention and the many tools and techniques to manage bifurcations, calcification and chronic occlusions.

He is committed to teaching and has trained many physicians both in UK and Internationally in devices such as Rotational and Laser Atherectomy, technical skills such as those involved in bifurcation stenting and coronary imaging utilisation. He has presented at many Cardiology conferences and performed as a live case operator. He has contributed to 30 global research studies as local principal investigator with high provision of randomised patients and has co-authored more than 50 manuscripts in addition to 10 book chapters.

View full profile